Industry
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
Failure Rate
50.0%
2 terminated/withdrawn out of 4 trials
Success Rate
50.0%
-36.5% vs industry average
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 4
2(50.0%)
Phase 2
2(50.0%)
4Total
Phase 4(2)
Phase 2(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT04348513Phase 2Terminated
Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection
Role: lead
NCT04344951Phase 2Terminated
Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
Role: lead
NCT03524651Phase 4Completed
Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia
Role: lead
NCT02283203Phase 4Completed
A New Formulation of Intravenous Paracetamol for Fever Management
Role: lead
All 4 trials loaded